Shenyang Agricultural University, Shenyang, China.
J Appl Microbiol. 2010 Sep;109(3):792-8. doi: 10.1111/j.1365-2672.2010.04707.x.
This study examined the transformation pathways of ginsenosides G-Rb(1) , G-Rb(3) , and G-Rc by the fungus Fusarium sacchari.
Ginsenosides G-Rb(1) , G-Rb(3) and G-Rc were isolated from leaves of Radix notoginseng, and their structural identification was confirmed using NMR. Transformation of G-Rb(1) , G-Rb(3) and G-Rc by Fusarium sacchari was respectively experimented. Kinetic evolutions of G-Rb(1) , G-Rb(3) and G-Rc and their metabolites during the cell incubation were monitored by HPLC analysis. High-performance liquid chromatography (HPLC) was used for monitoring the transformation kinetics of bioactive compounds during F. sacchari metabolism.
Ginsenoside C-K was transformed by F. sacchari from G-Rb(1) via G-Rd or via G-F(2) , or from G-Rb(1) via firstly Rd and then G-F(2) , and C-Mx was transformed by F. sacchari or directly from Rb(3) , or from Rb(3) via Gy-IX, while G-Mc was transformed by F. sacchari directly from G-Rc. Furthermore, C-K could be also formed from G-Rc via notoginsenoside Fe (N-Fe).
The results showed an important practical application in the preparation of ginsenoside C-K. As our precious research indicated C-K possessed much more antitumor activities than C-Mx and G-Mc, so according to the transformation pathways proposed by this work, the production of antitumor compound C-K may be performed by biotransformation of G-Rb(1) previously isolated from PNLS.
本研究考察了真菌镰孢菌对人参皂苷 G-Rb(1)、G-Rb(3)和 G-Rc 的转化途径。
从三七叶中分离得到人参皂苷 G-Rb(1)、G-Rb(3)和 G-Rc,并通过 NMR 确定其结构。分别对 G-Rb(1)、G-Rb(3)和 G-Rc 与镰孢菌的转化进行了实验。通过 HPLC 分析监测细胞孵育过程中 G-Rb(1)、G-Rb(3)和 G-Rc 及其代谢物的动力学演变。高效液相色谱(HPLC)用于监测 F. sacchari 代谢过程中生物活性化合物的转化动力学。
镰孢菌可将 G-Rb(1)转化为 C-K,途径为 G-Rd 或 G-F(2),也可先由 Rd 转化为 G-F(2),再由 G-Rb(1)转化为 C-K,C-Mx 可由 Rb(3)或直接由 Rb(3)转化而来,也可由 Gy-IX 转化而来,G-Mc 可由 F. sacchari 直接转化而来。此外,C-K 也可由 G-Rc 通过 notoginsenoside Fe(N-Fe)形成。
该研究结果在制备人参皂苷 C-K 方面具有重要的实际应用价值。如我们的研究表明,C-K 的抗肿瘤活性比 C-Mx 和 G-Mc 更强,因此,根据本工作提出的转化途径,可通过生物转化先前从 PNLS 中分离得到的 G-Rb(1)来生产抗肿瘤化合物 C-K。